Eli Lilly Enters R&D and Licensing Deal with Haisco, Up to $3 Billion in Milestones
Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment
Positive
Importance
7
Price
$1,096.15
Mkt Cap
$1.041T
52W Low
$623.78
52W High
$1,149.1
52W Position
76% above low
Off High
4.6% below high
Rel. Volume
1.5× avg
Market data snapshot near publication time
LLY sits 76% above its 52-week low of $623.78.
Summary
Eli Lilly has signed a licensing and R&D collaboration agreement with Haisco Pharmaceutical. The deal includes up to $87 million in upfront and near-term payments to Haisco, with potential for an additional $3.0 billion in subsequent milestone payments. This expands Eli Lilly's research pipeline, adding a new development program.
At the time of this announcement, LLY was trading at $1,096.15 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1T. The 52-week trading range was $623.78 to $1,149.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.
Price Chart
LLY - Latest Insights
LLY
Jul 24, 2026, 4:33 AM EDT
Price at Filing:
$1,185.92
Real-time Price:
$1,196.97
Change:
+$11.05 (+0.93%)
Market Cap:
$1.126T
LLY
Jul 23, 2026, 6:35 AM EDT
Price at Filing:
$1,176.80
Real-time Price:
$1,196.97
Change:
+$20.17 (+2%)
Market Cap:
$1.126T
LLY
Jul 21, 2026, 7:58 AM EDT
Price at Filing:
$1,140.88
Real-time Price:
$1,196.97
Change:
+$56.09 (+5%)
Market Cap:
$1.126T
LLY
Jul 16, 2026, 8:53 AM EDT
Price at Filing:
$1,165.76
Real-time Price:
$1,196.97
Change:
+$31.21 (+3%)
Market Cap:
$1.126T
LLY
Jul 16, 2026, 5:36 AM EDT
Price at Filing:
$1,158.00
Real-time Price:
$1,196.97
Change:
+$38.97 (+3%)
Market Cap:
$1.126T